Resistance Training and Appetite Regulation

September 22, 2021 updated by: University of Colorado, Denver

The Effects of Resistance Training on Appetite Regulation

This study plans to learn more about how resistance training impacts appetite and the brain's response to food. The study will be evaluating how the brain responds to food images as well as how behaviors and hormones change with a 12 week resistance training intervention.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

Aim 1: To determine if RT impacts neuronal function associated with food intake behavior in a manner favoring reduced EI in overweight/obese adults.

Hypothesis: Compared to pre, post-RT fMRI measures will demonstrate ↓ neuronal responses to food cues in the insula, prefrontal cortex, and hypothalamus, brain regions implicated in reward, impulsivity, motivation, and regulation of ingestive behaviors. These changes will be associated with ad libitum EI.

Aim 2: To determine if RT impacts appetite-related peptides, ratings, and food intake behaviors in a manner favoring reduced EI in overweight/obese adults.

Hypothesis: Compared to pre, post-RT measures will show changes in appetite-related peptides, ratings (↓ hunger ↑ satiety), and behaviors (↓food-related cravings & impulsivity, ↑ self-efficacy) consistent with EI reduction. Changes in appetite regulation indices will be associated with changes in relevant brain networks (Aim 1). These changes will also be associated with ↓ ad libitum EI.

Exploratory Aim: To determine if RT impacts neuronal function and appetite-related peptides and behaviors in a manner favoring ↓ EI in Non-Compensators (top tertile of fat mass loss) as compared to Compensators (bottom tertile of fat mass loss).

Hypothesis: Compared to Compensators, Non-Compensators will show ↓ neuronal responses to food cues and default network, and changes in appetite-related peptides, ratings, and behaviors consistent with ↓ EI.

Study Type

Interventional

Enrollment (Actual)

23

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Colorado
      • Aurora, Colorado, United States, 80045
        • University of Colorado Denver - Anschutz Medical Campus

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 55 years (Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • all ethnic groups
  • both sexes
  • age: 18-55
  • BMI: 27-40 kg/m2
  • weight stable (±5% in last 6 months)
  • sedentary (<2 hours of planned physical activity/week by self-report, no RT in previous 12-months)

Exclusion Criteria:

  • history of CVD
  • DM
  • uncontrolled Hypertension
  • untreated thyroid disease
  • renal disease
  • hepatic disease
  • other condition affecting weight/metabolism
  • unable to exercise
  • smoker
  • medications affecting weight
  • EI or EE in past 6 months
  • weight loss/gain >5% in past 6 months
  • post-menopausal women (defined as age appropriate women with 6 months or more of amenorrhea)
  • currently pregnant, lactating, < 6 months post-partum
  • woman who have undergone oophorectomy
  • bariatric surgery
  • major psychiatric disorder
  • alcohol or substance abuse
  • depression by history and/or score >21 on CES-D
  • history of eating disorders and/or score >20 on EATS-26

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: All Participants
12-weeks of a full body resistance training intervention. Intervention will consist of 4 training sessions per week that are approximately 45-minutes in length. Two days will be upper body training and 2 days lower body
12-weeks of a full body resistance training intervention. Intervention will consist of 4 training sessions per week that are approximately 45-minutes in length. Two days will be upper body training and 2 days lower body

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Neuronal Responses to Food Cues in Regions of Interest
Time Frame: Baseline, 12 Weeks
Changes in the insula, prefrontal cortex, and hypothalamus response to salient food cues (pre vs post-RT) as measured by fMRI in response to 12-weeks of RT
Baseline, 12 Weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Whole Brain Response
Time Frame: Baseline, 12 Weeks
Whole brain changes in response to salient food cues (pre vs post RT) as measured by fMRI in response to 12-weeks of RT
Baseline, 12 Weeks
Change in Default Mode Network
Time Frame: Baseline, 12 Weeks
Changes in the DMN resting state activity and large-scale network connectivity (pre vs post RT) as measured by MRI in response to 12-weeks of RT
Baseline, 12 Weeks
Changes in Appetite Ratings
Time Frame: Baseline, 12 Weeks
Changes in measures of appetite (hunger, satiety, and prospective food consumption) area under the curve [AUC] following a standardized test-meal in response to 12-weeks of RT.
Baseline, 12 Weeks
Changes in Appetite-Related Hormones
Time Frame: Baseline, 12 Weeks
Changes in appetite-related hormones [ghrelin, PYY, and GLP-1] area under the curve [AUC] following a standardized test meal in response to 12-weeks of RT.
Baseline, 12 Weeks
Change in In Lab Ad Libitum Energy Intake (kcals)
Time Frame: Baseline, 12 Weeks
Change in In lab ad libitum buffet lunch (via weigh and measure methodology) three hours after breakfast test meal at baseline and post-intervention
Baseline, 12 Weeks
Change in Free-Living Ad libitum Energy Intake (kcals)
Time Frame: Baseline, 12 Weeks
Change in Three days of free-living ad libitum energy intake (via DHQ food frequency questionnaire) at baseline and post intervention.
Baseline, 12 Weeks

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Changes in Free-Living Physical Activity and Sedentary Time
Time Frame: Baseline, 12 Weeks
Physical Activity and Sedentary Time will be measured via activPAL (PALTechnologies: Glasgow, Scotland) activity monitor. Participants will be instructed to wear the monitor on their right leg for 7 consecutive days at all times except when sleeping or participating in water-based activities (e.g. showering, swimming). The time-stamped "event" data file from the activPAL software will be used to determine time spent sitting/lying, standing and stepping per day.
Baseline, 12 Weeks
Changes in Muscular Strength
Time Frame: Baseline, 12 Weeks
Muscular Strength via 10 repetition maximum of chest and leg press on strength training machines, respectively.
Baseline, 12 Weeks
Change in Body Mass (kg)
Time Frame: Baseline, 12 Weeks
Via Digital scale
Baseline, 12 Weeks
Change in Body Composition
Time Frame: Baseline, 12 Weeks
Assessment of fat mass and lean mass via DXA scan
Baseline, 12 Weeks
Change in Neuronal Responses to Food Cues in Regions of Interest by Non-Compensator vs. Compensator groups
Time Frame: Baseline, 12 Weeks
Changes in the insula, prefrontal cortex, and hypothalamus response to salient food cues (pre vs post-RT) as measured by fMRI in response to 12-weeks of RT. "Non-Compensators" (will be defined as those who lose weight in response to the 12-week resistance training intervention. "Compensators" will be defined as those who maintain or gain weight in response to the 12-week resistance training interventions.
Baseline, 12 Weeks
Change in Neuronal Responses to Food Cues in Regions of Interest by Sex
Time Frame: Baseline, 12 Weeks
Changes in the insula, prefrontal cortex, and hypothalamus response to salient food cues (pre vs post-RT) as measured by fMRI in response to 12-weeks of RT.
Baseline, 12 Weeks
Change in Whole Brain Response by Non-Compensator vs. Compensator groups
Time Frame: Baseline, 12 Weeks
Whole brain changes in response to salient food cues (pre vs post RT) as measured by fMRI in response to 12-weeks of RT. "Non-Compensators" (will be defined as those who lose weight in response to the 12-week resistance training intervention. "Compensators" will be defined as those who maintain or gain weight in response to the 12-week resistance training interventions.
Baseline, 12 Weeks
Change in Whole Brain Response by Sex
Time Frame: Baseline, 12 Weeks
Whole brain changes in response to salient food cues (pre vs post RT) as measured by fMRI in response to 12-weeks of RT.
Baseline, 12 Weeks
Change in Default Mode Network by Non-Compensator vs. Compensator groups
Time Frame: Baseline, 12 Weeks
Changes in the DMN resting state activity and large-scale network connectivity (pre vs post RT) as measured by MRI in response to 12-weeks of RT. "Non-Compensators" (will be defined as those who lose weight in response to the 12-week resistance training intervention. "Compensators" will be defined as those who maintain or gain weight in response to the 12-week resistance training interventions.
Baseline, 12 Weeks
Change in Default Mode Network by Sex
Time Frame: Baseline, 12 Weeks
Changes in the DMN resting state activity and large-scale network connectivity (pre vs post RT) as measured by MRI in response to 12-weeks of RT.
Baseline, 12 Weeks
Changes in Appetite Ratings by Non-Compensator vs. Compensator groups
Time Frame: Baseline, 12 Weeks
Changes in measures of appetite (hunger, satiety, and prospective food consumption) area under the curve [AUC] following a standardized test-meal in response to 12-weeks of RT. "Non-Compensators" (will be defined as those who lose weight in response to the 12-week resistance training intervention. "Compensators" will be defined as those who maintain or gain weight in response to the 12-week resistance training interventions.
Baseline, 12 Weeks
Changes in Appetite Ratings by Sex
Time Frame: Baseline, 12 Weeks
Changes in measures of appetite (hunger, satiety, and prospective food consumption) area under the curve [AUC] following a standardized test-meal in response to 12-weeks of RT. "
Baseline, 12 Weeks
Changes in Appetite-Related Hormones by Non-Compensator vs. Compensator groups
Time Frame: Baseline, 12 Weeks
Changes in appetite-related hormones [ghrelin, PYY, and GLP-1] area under the curve [AUC] following a standardized test meal in response to 12-weeks of RT. "Non-Compensators" (will be defined as those who lose weight in response to the 12-week resistance training intervention. "Compensators" will be defined as those who maintain or gain weight in response to the 12-week resistance training interventions.
Baseline, 12 Weeks
Changes in Appetite-Related Hormones by Sex
Time Frame: Baseline, 12 Weeks
Changes in appetite-related hormones [ghrelin, PYY, and GLP-1] area under the curve [AUC] following a standardized test meal in response to 12-weeks of RT.
Baseline, 12 Weeks
Change in In Lab Ad Libitum Energy Intake (kcals) by Non-Compensator vs. Compensator groups
Time Frame: Baseline, 12 Weeks
Change in In lab ad libitum buffet lunch (via weigh and measure methodology) three hours after breakfast test meal at baseline and post-intervention. "Non-Compensators" (will be defined as those who lose weight in response to the 12-week resistance training intervention. "Compensators" will be defined as those who maintain or gain weight in response to the 12-week resistance training interventions.
Baseline, 12 Weeks
Change in In Lab Ad Libitum Energy Intake (kcals) by Sex
Time Frame: Baseline, 12 Weeks
Change in In lab ad libitum buffet lunch (via weigh and measure methodology) three hours after breakfast test meal at baseline and post-intervention.
Baseline, 12 Weeks
Change in Free-Living Ad libitum Energy Intake (kcals) by Non-Compensator vs. Compensator groups
Time Frame: Baseline, 12 Weeks
Change in Three days of free-living ad libitum energy intake (via DHQ food frequency questionnaire) at baseline and post intervention. "Non-Compensators" (will be defined as those who lose weight in response to the 12-week resistance training intervention. "Compensators" will be defined as those who maintain or gain weight in response to the 12-week resistance training interventions.
Baseline, 12 Weeks
Change in Free-Living Ad libitum Energy Intake (kcals) by Sex
Time Frame: Baseline, 12 Weeks
Change in Three days of free-living ad libitum energy intake (via DHQ food frequency questionnaire) at baseline and post intervention.
Baseline, 12 Weeks
Changes in Free-Living Physical Activity and Sedentary Time by Non-Compensator vs. Compensator groups
Time Frame: Baseline, 12 Weeks
Physical Activity and Sedentary Time will be measured via activPAL (PALTechnologies: Glasgow, Scotland) activity monitor. Participants will be instructed to wear the monitor on their right leg for 7 consecutive days at all times except when sleeping or participating in water-based activities (e.g. showering, swimming). The time-stamped "event" data file from the activPAL software will be used to determine time spent sitting/lying, standing and stepping per day. "Non-Compensators" (will be defined as those who lose weight in response to the 12-week resistance training intervention. "Compensators" will be defined as those who maintain or gain weight in response to the 12-week resistance training interventions.
Baseline, 12 Weeks
Changes in Free-Living Physical Activity and Sedentary Time by Sex
Time Frame: Baseline, 12 Weeks
Physical Activity and Sedentary Time will be measured via activPAL (PALTechnologies: Glasgow, Scotland) activity monitor. Participants will be instructed to wear the monitor on their right leg for 7 consecutive days at all times except when sleeping or participating in water-based activities (e.g. showering, swimming). The time-stamped "event" data file from the activPAL software will be used to determine time spent sitting/lying, standing and stepping per day.
Baseline, 12 Weeks
Change in Muscular Strength by Non-Compensators vs Compensators
Time Frame: Baseline, 12 Weeks
Muscular Strength via 10 repetition maximum of chest and leg press on strength training machines, respectively. "Non-Compensators" (will be defined as those who lose weight in response to the 12-week resistance training intervention. "Compensators" will be defined as those who maintain or gain weight in response to the 12-week resistance training interventions.
Baseline, 12 Weeks
Change in Muscular Strength by Sex
Time Frame: Baseline, 12 Weeks
Muscular Strength via 10 repetition maximum of chest and leg press on strength training machines, respectively.
Baseline, 12 Weeks
Change in Body Mass by Non-Compensator vs. Compensator groups
Time Frame: Baseline, 12 Weeks
Via Digital scale. "Non-Compensators" (will be defined as those who lose weight in response to the 12-week resistance training intervention. "Compensators" will be defined as those who maintain or gain weight in response to the 12-week resistance training interventions.
Baseline, 12 Weeks
Change in Body Mass by Sex
Time Frame: Baseline, 12 Weeks
Via Digital scale.
Baseline, 12 Weeks
Change in Body Composition by Non-Compensator vs. Compensator groups
Time Frame: Baseline, 12 Weeks
Assessment of fat mass and lean mass via DXA scan. "Non-Compensators" (will be defined as those who lose weight in response to the 12-week resistance training intervention. "Compensators" will be defined as those who maintain or gain weight in response to the 12-week resistance training interventions.
Baseline, 12 Weeks
Change in Body Composition by Sex
Time Frame: Baseline, 12 Weeks
Assessment of fat mass and lean mass via DXA scan.
Baseline, 12 Weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 24, 2018

Primary Completion (Actual)

May 31, 2021

Study Completion (Actual)

May 31, 2021

Study Registration Dates

First Submitted

April 11, 2019

First Submitted That Met QC Criteria

June 10, 2019

First Posted (Actual)

June 14, 2019

Study Record Updates

Last Update Posted (Actual)

September 28, 2021

Last Update Submitted That Met QC Criteria

September 22, 2021

Last Verified

September 1, 2021

More Information

Terms related to this study

Other Study ID Numbers

  • 18-1298
  • 1R21DK115200-01A1 (U.S. NIH Grant/Contract)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Obesity

Clinical Trials on Resistance Training

3
Subscribe